A Multiple Dose Study To Determine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP05195 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2013
At a glance
- Drugs DWP 05195 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 08 Feb 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 08 Feb 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 New trial record